Here's What $1,000 Invested in Nebius Could Be Worth by 2030

Nebius’ revenue rose 351% to $530 million in 2025 and 529% year over year to $981 million in the first half of 2026; adjusted EBITDA turned positive at $366 million, while its Q2 2026 contracted backlog topped $40 billion. The article says the stock, at about $220, could rise roughly ninefold by the end of 2030 if it meets analyst estimates through 2028, grows adjusted EBITDA at a 30% CAGR thereafter, and trades at 25x forward adjusted EBITDA. That scenario is conditional and carries risks from GAAP losses, rising debt and dilution, interest rates, and capital-intensive data-center expansion.

Analysis

The key underwriting question is not demand but conversion: whether contracted commitments become energized capacity, billable utilization, and collected cash on schedule. A large backlog is less protective if contracts allow deferrals or cancellations, or if customer concentration leaves buyers with negotiating leverage. Verify contract duration, cancellation terms, deposits, and customer concentration.

Owning facilities may create durable asset value and reduce dependence on landlords, but it also moves more construction, power procurement, and financing risk onto Nebius. Depreciation and interest can widen the gap between adjusted EBITDA and GAAP earnings; EBITDA growth alone therefore does not establish attractive equity returns. Rising capacity also brings GPU obsolescence risk before facilities are fully monetized. CoreWeave is a useful operating comparator, not an automatic hedge: its leased footprint changes the cost and balance-sheet trade-offs, so relative valuation and contractual obligations need comparison before pairing.

Near term, avoid extrapolating the article’s optimistic projections into a straight-line multiple expansion. Over the next 1–3 months, commissioning pace, customer acceptance, cash collections, and funding terms matter more than announced capacity. Over 6–18 months, power availability, utilization, dilution, and the cost of capital determine whether growth accrues to equity holders. The contrarian risk is that investors may be valuing an asset-heavy, financing-sensitive infrastructure operator on adjusted earnings as if those earnings were largely distributable. The thesis strengthens if capacity and cash conversion track commitments without repeated equity raises; it weakens on delayed commissioning, softer guidance, or widening GAAP-to-adjusted losses.

Key Decisions for Investors

• Do not chase NBIS on backlog or adjusted EBITDA headlines alone. Treat it as a conditional long: consider a staged position only after the next results show commissioned capacity translating into recognized revenue and cash collections, with funding needs disclosed clearly. Keep the thesis small until those conversion metrics are observable.
• Make the next earnings release the 1–3 month catalyst check. Track capacity actually energized and available to customers, utilization, revenue per deployed capacity, operating cash flow, net debt, share-count growth, and any guidance changes. Delayed capacity or materially weaker cash conversion falsifies the near-term execution case.
• Do not initiate a NBIS/CRWV pair solely on the ownership-versus-leasing distinction. First compare valuation, customer and contract concentration, financing obligations, and delivery economics. If NBIS execution or financing deteriorates while exposure is held, consider reducing shares or using a put spread only after confirming options liquidity and pricing.